POPULARITY
What happens when you blend the soul of Mr. Rogers, the boldness of RuPaul, and just a pinch of Carrie Bradshaw? You get Sally Wolf.She's a Harvard and Stanford powerhouse who ditched corporate media to help people actually flourish at work and in life—because cancer kicked her ass and she kicked it back, with a pole dance routine on Netflix for good measure.In this episode, we unpack what it means to live (really live) with metastatic breast cancer. We talk about the toxic PR machine behind "pink ribbon" cancer, how the healthcare system gaslights survivors when treatment ends, and why spreadsheets and dance classes saved her sanity. Sally doesn't just survive. She rewrites the script, calls out the BS, and shows up in full color.If you've ever asked “Why me?”—or refused to—this one's for you.RELATED LINKS:Sally Wolf's WebsiteLinkedInInstagramCosmopolitan Essay: "What It's Like to Have the 'Good' Cancer"Oprah Daily Article: "Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis"Allure Photo ShootThe Story of Our Trauma PodcastFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Matters Microbial #91: You Are What Your Genes Feed Your Microbiome May 16, 2025 Today, Dr. Emily Davenport, Assistant Professor in the Department of Biology and Huck Institutes of the Life Sciences at Penn State University, joins the #QualityQuorum to tell us about the research her team does, studying how our own genes impact our microbiomes. Host: Mark O. Martin Guest: Emily Davenport Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A description of GWAS (“Genome Wide Association Study”). Here is an introductory video about the concept. An explainer on organoids. An essay about the diversity of the host microbiome (i.e. is there a “healthy” microbiome?). An article of the work of Dr. Sarkis Mazamian on how individual host genes and bacterial genes can impact the microbiome. A nice write up for Dr. Mazamian's work showing how host genes and bacterial genes can work together…or not. An oldish video of how the infant microbiome develops over time by Dr. Rob Knight's research group. An article on the same topic from Dr. Ruth Ley. An essay on the mucosal microbiota, rather than the fecal microbiome. An interesting member of the human microbiome, Akkermansia that might be related to obesity. Another interesting member of the human microbiome, Bifidobacterium, which appears to be associated with host lactose metabolism. Yes, there is a Giant Microbes plush toy. An overview of the impact of host genetics on the microbiome by Dr. Davenport. A definition of heritability. An overview of the Hutterites and how their study has advanced genetics. An explainer of the power of twin studies in genetics. A fascinating article about ancient dental plaque microbiome by Dr. Davenport and others. Dr. Davenport's faculty website. Dr. Davenport's research group website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com
In this episode of Investor Connect, we welcome Alan Foreman, the CEO of Be Secure, who discusses the transformative journey of his company in the realm of heart health. Alan shares that he founded Be Secure nine years ago after a lengthy career in Accenture's Life Sciences division. Currently, the company is on a $12 million growth raise to commercialize its breakthrough heart health technology, which received FDA clearance recently. Be Secure focuses on making preventive rather than reactive heart health solutions, leveraging their powerful, device-agnostic software that offers high accuracy ECG readings in consumer and medical devices alike, such as the latest versions of the Whoop and Fitbit devices. Alan elaborates on how the recent challenges faced by Philips, a significant player in heart monitoring technology, present both a testament to the need for better solutions and an opportunity for Be Secure to make a substantial impact on the market. Alan details the company's innovative use of cybersecurity experts and detailed signal processing to develop technology that bridges consumer wellness and medical-grade ECG technology. He highlights how Be Secure's cloud-based and on-device solutions offer transformative accuracy and efficiency in heart monitoring, even earning the interest of major insurers like Blue Cross Blue Shield. The conversation turns to the scalability and swift deployment of Be Secure's solutions in medical environments, emphasizing how their data quality can accelerate and improve diagnosis in cardiologists' workflows. Alan stresses the importance of their upcoming scale-up and commercial focus, particularly in filling the funding gap to expedite the deployment of their remarkable technology in the healthcare space. We also learn about Be Secure's financials and investment strategy, which involves contributions from venture capital and venture debt providers. Alan emphasizes ongoing discussions with top medical companies and the anticipated rapid revenue growth fueled by the latest FDA clearance. The episode wraps with Alan addressing some practical questions about scaling, design timelines, and the lifecycle of deals with their partners, giving a comprehensive view of Be Secure's promising future. For more updates and opportunities to engage with Alan and Be Secure, stay tuned to Investor Connect. Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: Check out our other podcasts here: For Investors check out: For Startups check out: For eGuides check out: For upcoming Events, check out For Feedback please contact info@tencapital.group Please , share, and leave a review. Music courtesy of .
Clay is an American inventor and serial entrepreneur who holds more than 250 patents worldwide and is the Founder and Chairman of Ember, a global consumer electronics and life sciences brand best known for the Ember Mug, Ember Baby Bottle, and Ember Cube, all three of which independently have been named TIME Magazine's Best Inventions of the year. Ember was also recently named one of TIME Magazine's 100 Most Influential Companies in the world. Top 3 Value Bombs 1. Founder's gut can be a very powerful thing. 2. The team is the No. 1 factor. Putting together an incredible powerhouse team is key. 3. Inch by inch life's a cinch. Buy the yard, life's hard. Take one bite at a time and keep chugging it forward. Check out Clay's patented technology temperature control mugs and other products - Ember Sponsors The Speaker Lab - Want to learn how to get booked and paid to speak. Go to EOFire.com/speaker to grab your spot for our LIVE training on May 28th, and learn how to get booked and paid to speak. ThriveTime Show - Become the next success story, schedule a free consultation and request tickets to join Football Star, Tim Tebow and President Trump's Son, Eric Trump at Clay Clark's next business conference today at - ThrivetimeShow.com/eofire.
Channing Hamlet, Managing Director and Co-Founder of Objective, Investment Banking & Valuation, joins Amanda Ma, CEO & Founder of Innovate Marketing Group, to discuss the rising "flight to quality" in the event industry. Learn how consolidation is transforming the landscape — and how event businesses can adapt, scale, and thrive in a shifting market.About the guest:Channing Hamlet is the Managing Director and Co-Founder of Objective, Investment Banking & Valuation. He leads the firm's Business Services & Life Sciences Practice. With over 25 years of experience in investment banking and business valuation, Channing brings deep expertise and strategic insight to Objective's clients. His recent notable transactions include the sale of 360 Destination Management to H.I.G. Capital and Supreme to Trinity Hunt Partners. An active member of the Los Angeles advisor community, Channing has served on the boards of the Exit Planning Institute, ACG LA, and EO LA. He is also passionate about philanthropy, particularly through his involvement with Reality Changers. Prior to joining Objective, Mr. Hamlet served as a Managing Director of Cabrillo Advisors, where he was instrumental in both leading their M&A execution and growing the valuation practice from inception into a national entity serving more than 700 clients in five years. Previously, he served as a Director at Vistage; Principal at LLR Partners, a $260 million private-equity firm; and member of Legg Mason's Investment Banking group. He has a Master's Degree in Operations Research and a Bachelor of Science in Mechanical Engineering from Cornell University. He holds FINRA Series 7, 63 and 79 licenses and is a Registered Representative of BA Securities LLC, Member FINRA SIPC.Connect with Channing Hamlet on LinkedIn hereRead about the sale of 360 Destination Management Group hereDownload the The Introspective CEO's Guide to Selling a Business, a high-level workbook covering key considerations for those contemplating a sale here.Objective, Investment Banking & Valuation is a leading firm serving middle market companies across key industries including Business Services, Consumer, Healthcare Tech, Life Sciences, Manufacturing, and Technology. We offer M&A advisory through our investment banking group and a full suite of valuation services for tax, financial reporting, and strategic planning. Since 2006, our team has completed over 500 M&A deals and thousands of valuations. Learn more at objectiveibv.comThis podcast episode is for informational purposes only and does not constitute investment, legal, or tax advice. Securities offered through BA Securities, LLC, Member FINRA, SIPC. Objective and BA Securities, LLC are separate, unaffiliated entities.EventUp is brought to you by Innovate Marketing Group. An award-winning Corporate Event and Experiential Marketing Agency based in Los Angeles, California. Creating Nationwide Immersive Event Experiences to help brands connect with people. To learn more, click here.Follow us!Find us on LinkedIn, EventUp Podcast LinkedIn , and Instagram
Solving the “Undruggable” Disease Problem with Goldilocks MoleculesIn this episode, Christian Schafmeister, Founder and President of Third Law Molecular, reveals a new class of therapeutics designed to target what most consider “undruggable” diseases—conditions like Alzheimer's, certain cancers, and rare genetic disorders.Christian explains the science behind spiroligomers—modular, mid-sized molecules that act like molecular LEGOs, offering the perfect balance between small molecules and biologics. Learn how his team created a library of 4.5 billion molecules and what makes these structures uniquely suited to bind difficult protein targets, including disordered proteins and intracellular surfaces.We also talk about the Goldilocks Zone of drug design, how Third Law's chemistry was born out of academic and defense-backed research, and why the future of drug discovery may lie in designing therapeutics that are just right.
Today's guest is Brice Challamel, Head of AI products and Innovation at Moderna. With experience working across five continents, he brings a global perspective to driving AI adoption, innovation management, and measurable results in life sciences. Brice joins Emerj Managing Editor Matthew DeMello to explore how Moderna is embedding AI into both its tools and corporate culture to scale collaboration, accelerate product development, and improve regulatory outcomes. He breaks down how AI is augmenting human creativity, enhancing team decision-making, and supporting patient engagement efforts, while keeping human insight at the center of AI strategy. Brice also shares lessons from other industries to shed light on what's ahead for AI in regulated sectors like life sciences, where the technology has the potential to improve operational efficiency, vaccine adoption, and broader public health outcomes. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj's flagship ‘AI in Business' podcast! This episode is sponsored by MSTRO. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
In this episode, host Sandy Vance sits down with Dr. Will Morris, Chief Medical Officer at Ambience Healthcare, to explore how AI is transforming the healthcare industry. From enhancing clinical documentation to improving patient care and supporting back-office operations, Ambience is creating intelligent solutions tailored for the entire healthcare ecosystem.Dr. Morris shares insights on how AI, when used as an assistive—not replacement—tool, can help alleviate clinician burnout and empower medical professionals to focus on what matters most: delivering compassionate, human-centered care. Whether you're a healthcare leader, clinician, or innovator, this episode offers practical insights into leveraging AI to drive real value across your organization.In this episode, they talk about:● AI should assist—not replace—medical professionals, enabling them to focus on essential human-centered care.● AI is not a commodity; it must address critical pain points to drive real value.● Ambient AI must work for all specialties, not just primary care. AI models must be tuned to the nuances of each specialty.● Reducing burnout is just the start. When coding-aware, Ambient AI greatly improves clinical documentation integrity and provides coding support at the point-of-care, capturing other lost revenue.● Always measure results, outputs, and processes when implementing new healthcare technologies.● The effectiveness of any system depends on the quality and consistency of clinical documentation.● Successful AI adoption requires a unified, enterprise-wide strategy.A Little About Will:Will Morris, MD, MBA, is board-certified in Internal Medicine and is a health technology leader, currently serving as Chief Medical Officer at Ambience Healthcare. In this role, he drives the company's vision for clinical AI, collaborating with leading health systems to transform clinician workflows and improve patient care. Before joining Ambience, Dr. Morris was Chief Medical Information Officer at Google Cloud Healthcare and Life Sciences, contributing to cutting-edge healthcare innovations. He previously held leadership roles at Cleveland Clinic, including Chief Innovation Officer and Associate Chief Information Officer, overseeing clinical IT systems and health IT advancements.
In this episode, Stephanie Major, a senior at Iowa State University, outlines a research project that aimed to better understand how bacon becomes discolored under varying types of retail lights. With Major as co-leader of the research team, the study involved treating cured bacon with natural antioxidants and then packaging the product in aerobic (overwrap) and anaerobic (vacuum packed) containers. Major and Dr. Terry Hauser, associate director at Iowa State's College of Agriculture and Life Sciences, explain the results of the study, which found that the type of packaging was more effective than an antioxidant treatment alone in preventing photo-oxidation in bacon in storage or on retail shelves.
Written by Robert Thomas and Sarah Batchelor & narrated by Gayle Grew. This article explores key design principles for creating life sciences spaces that enhance collaboration among scientists, researchers, and professionals.
In this powerful episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Katrina Rogers, a 25-year life sciences veteran, biotech equity advocate, and founder of Evergreen Bioscience Innovation and Katrina Rogers Consulting. Katrina shares her compelling journey from Pfizer to pioneering innovation ecosystems and mentoring underrepresented biotech founders. They unpack the role of board governance, the funding gap for female founders, and how "showing your science" is critical for regulatory success. Katrina also warns of dangerous gaps in understanding between regulators and innovators and why we must protect our basic science infrastructure. If you've ever dreamed of launching a breakthrough therapy, leading a biotech, or making your idea count, this episode is for you.00:00 Episode Preview & BioTalk Unzipped Introduction03:09 Katrina's Charity Highlight: 2nd Harvest (link below)04:04 Defining Moment in Life Science05:35 Launching a Consultancy: Overcoming Fears07:12 Leadership Lessons09:30 The Importance of Board Composition13:08 NEW NEWS: The Case for Female Founders18:04 Knowledge Gaps Between Founders and Regulators20:23 The Impact of Regulatory Changes21:32 The Direct Attack on Basic Scientific Infrastructure25:57 Understanding Market Needs29:36 The Role of Founders in Leadership and Navigating Leadership Challenges34:00 The Most Common Mistake by Biotech Founders & What To Do35:27 Katrina's Scope & Delivering Unpleasant News36:51 NEW NEWS: Understanding Tariffs and Drug Pricing42:23 Empowering Big Ideas45:26 Overcoming Systemic Barriers47:24 Advice to My Younger Self49:38 Proposing Changes to FDA Innovation Pathways54:54 The Future of Innovation in BiotechnologyKatrina Rogershttps://www.linkedin.com/in/katrinarogers/ https://krogersconsulting.com/ Katrina's Favorite Charity: 2nd Harvest (Food Bank) - https://2-harvest.org/ Dr. Chad Briscoehttps://www.linkedin.com/in/chadbriscoe/ Celerion - https://www.celerion.com/ Gregory Austinhttps://www.linkedin.com/in/gregoryaustin1/ Celerion - https://www.celerion.com/ NEW NEWSBiotech a Bright Spot for Female Founders Amid DEI Pullback, https://www.biospace.com/business/biotech-a-bright-spot-for-female-founders-amid-dei-pullback?utm_source=chatgpt.com Trump signals shift in drug import tariff policy
“Over 90% of people you meet in life sciences are going to be dealing with failure every day. You have to normalize failure in this industry to get the success you want,” says Beth Benatti Kennedy, discussing the unique pressures facing pharmaceutical professionals.Beth Benatti Kennedy brings more than two decades of experience as a leadership and resilience executive coach, working with major pharmaceutical companies including Takeda, Nautilus Biotechnology, and Pfizer. Beth is also the author of Career Recharge and co-author of ReThink ResilienceHer insights into preventing burnout have become increasingly relevant as the industry faces mounting pressures from accelerated development timelines and regulatory complexity. In this interview with PharmaSource, Beth shares critical strategies for building resilience.Read the full article
Comment on this episode by going to KDramaChat.comToday, we'll be discussing Episode 9 of When Life Gives You Tangerines, the hit K Drama on Netflix starring IU as Oh Ae-sun, Park Bo-gum as Yang Gwan-sik as young adults, and Moon So-ri as Oh Ae-sun and Park Hae-joon as Yang Gwan-sik as older adults. We discuss:The song featured during the recap: "Midnight Walk" by IU, a sweet ballad of longing that reflects Geum Myeong's and Ae Sun's emotional states of mind.How this episode subtly shifts focus to Geum Myeong as the central figure, possibly revealing the show as her coming-of-age story.The Baeksang Awards wins in 2025, including Best Drama, Best Supporting Actress, Best Supporting Actor, and Best Screenplay for When Life Gives You Tangerines!Our shoutouts to Lori and Seven Seas, who shared their love for the podcast and personal stories that echo themes in the show.The Yang family's move to a cramped apartment, and Ae-sun's determination to bring her cherished mother-of-pearl armoire to their new apartment.Eun Myeong's emotional journey—his bitterness, rebellion through hairstyles, and quiet gestures of love toward Ae Sun, like placing tennis balls under his mom's chair.Geum Myeong's return from Japan and the lack of exploration of her time abroad, which disappointed both of us.The awkward and growing connection between Geum Myeong and Park Chung Seop, who keep running into each other, and who the staff at the theater want to push closer together.The breakdown of Geum Myeong and Yeong-beom's relationship, and how Park Chung Seop might be quietly emerging as a romantic lead. Does Geum Myeong marry him in the end?The Romeo and Juliet parallel between Eun Myeong and Bu Hyeon-suk, son and daughter of two families that have been intertwined forever but are enemies!The beautiful poem “Natasha, the White Donkey and Me” by Baek Seok, read by Geum Myeong from Chung Seop's notebook.A spotlight on Lee Jun-young (Jun)—his career in K-pop and K Drama, including his rap and acting performances. We love him as Park Yeong Beom in this drama!How we're excited to watch the film "The Match" on Netflix, starring Lee Byung-hun and Yoo Ah-in. This movie is about an epic match Go between a mentor and mentee! ReferencesBloomberg Innovation Index in 2021Healthcare and Life Sciences as a Strategic Focus for South KoreaNatasha, the White Donkey and Me by Baek Seok‘Ghost' Director Lauds the Korean Sense of ResponsibilityCircle of Love by Lee Jun youngAmazing rap by Jun young of U KissKal-guksu - WikipediaJjolmyeon - Wikipedia
Recorded at SCBio's 2025 annual conference, hosts Heather and Matthew welcome keynote speaker John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), the world's leading advocacy group for the life sciences industry. In this inspiring episode, John shares his personal journey in biotech, including his fight to improve his children's lives after a rare disease diagnosis that inspired a major film, and offers insight into what lies ahead for the industry. Tune in to hear how his story and lifelong work are transforming lives and advancing science.
Why do most recruitment companies stall at 10 to 20 people, while others scale to 100+ across continents? In this episode, you'll hear directly from someone who's done it. STR Group is a family of specialist recruitment brands focused on STEM sectors. As co-founder, Clive Hutchings has spent over two decades growing the business to more than 120 staff across the UK, Europe, and the US—all while staying profitable, adaptable, and values-driven. In this interview, Clive breaks down what it really takes to build a multi-brand, international recruitment group, the leadership philosophy behind STR's culture, and the gritty truths behind scaling a business beyond yourself. Episode Outline and Highlights [3:05] The early days: how Clive started in recruitment and his story of practicing his pitch in front of a mirror in the office. [11:37] The operational and leadership shifts needed to grow from 10 to 100+ employees [19:19] Why many recruitment founders plateau—and how to avoid it [21:09] Discussion on the best approach to train a new recruiter. [27:33] The value of having a support network around you. [32:50] What is the formula for knowing when to make your next hire? [40:00] Impact of AI: “Sales people being more sustainable, resourcing people less so.” [41:45] Clive reveals their tech stack and how AI impacts their current operations. [45:00] The relevance of cold calling in the age of AI. [52:00] Big differences between hiring in the US and the UK. [1:02:10] Learnings on expanding globally. [1:07:00] Culture and mantra that work. Leadership That Scales One of the biggest takeaways from this conversation is the importance of evolving your role as a founder. Clive credits much of STR's growth to the fact that he didn't try to do everything himself. Instead, he and his co-founder took on complementary leadership roles, allowing each to focus on their strengths while building out a business that could scale beyond them. If you're stuck juggling billing, management, and strategy, this is your sign to rethink your leadership structure. Building a scalable firm means building scalable leadership, and that starts with letting go of being the bottleneck. He also elaborated on the following: 1. Multifaceted Leadership Structure 2. Team Composition and Talent Strategy 3. High Energy and Personal Drive 4. Resilience Through Early-Stage Challenges 5. Realistic Growth Mindset Clive's success as a leader came from building a balanced team, maintaining high personal energy, fostering a resilient and realistic culture, and adapting roles and structures to match the stage of the business. Decision Factors When to Make Your Next Hire With Clive's success in scaling his team globally, I wanted to pick his brains on his thought process when deciding to make a new hire. As a recruitment business owner, this is a critical decision to make, as doing it too slowly can impede your business's growth, while doing it too rapidly can lead to longer-term problems that cost more to fix. Clive shared the following decision factors: Strategic Forecasting & Business Planning - Hiring plans are based on quarterly forecasts developed by each brand's leadership. Critical Mass & Team Size Considerations - A certain headcount is needed to reach operational momentum, but hiring must be sustainable. Smaller teams (e.g.,
Today's guest is Marie Flanagan, Director of Product Management in Digital Projects and Solutions at IQVIA, who joins us to explore the overlooked intersection of AI and safety workflows in life sciences. As the industry experiences an explosion in the volume and diversity of data—from social media and call centers to audio and video files—Marie outlines the mounting challenges for pharmacovigilance and the opportunities AI is unlocking for healthcare and life sciences leaders. Marie discusses how advancements in voice-to-text transcription and automation are helping safety teams manage massive datasets, pinpoint potential risks, and reallocate human resources toward high-value activities like signaling and benefit-risk management. She also shares insights into where human expertise remains essential, particularly in interpreting complex clinical contexts that AI alone cannot fully capture. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj's flagship ‘AI in Business' podcast!
"You're not stuck—you're just scared to take up space."In this episode of The Counter Offer, host Susanna Gray is joined by her co-host for the season, recruiter-turned-career-coach Tiarna Mccormack. Tiarna brings sharp insight into the job search process, why women especially struggle to own their stories, and what it really takes to move your career forward. They dig into the unspoken power dynamics between recruiters and candidates, how burnout fuels bad decisions, and why quiet quitting might not be the answer you're looking for.If you've ever felt invisible in your career or doubted your next move, this episode will give you the mindset reset you didn't know you needed.Must-Hear Insights and Key MomentsFrom Recruiter to Coach – Tiarna shares her transition from the recruitment world to career coaching, explaining how personal burnout and professional misalignment led her to find deeper meaning in helping people unlock clarity and confidence.The Power of Owning Your Story – The conversation dives into why so many people—especially women—struggle to articulate their worth and how career coaching can help shift those narratives.Quiet Quitting: A Symptom, Not a Solution – Tiarna breaks down why quiet quitting is a red flag for deeper disengagement and how it can be an opportunity to reflect and pivot before you fully burn out.Recruiter Red Flags – Susanna and Tiarna expose what candidates often miss when dealing with recruiters and how to spot the signs that a role—or a recruiter—isn't aligned with your values.Job Search Mindset Reset – They unpack why desperation in a job search backfires and how reframing the process around curiosity and ownership leads to better long-term outcomes.Words of Wisdom: Standout Quotes from This Episode“When people come to me, they think the problem is their résumé—but it's really their relationship to their career.” – Tiarna Mccormack“You're not stuck—you're just scared to take up space.” – Tiarna Mccormack“Quiet quitting is a coping mechanism for something much deeper.” – Tiarna Mccormack“Owning your story is about reclaiming your career narrative before someone else writes it for you.” – Tiarna Mccormack“If a recruiter makes you feel small, that's a massive red flag.” – Tiarna Mccormack“Most of the time, people already know what they want—they just need permission to want it.” – Tiarna Mccormack“When you're desperate in a job search, you show up differently—and you attract the wrong opportunities.” – Susanna Gray“Your self-worth should not be tied to your job title.” – Tiarna Mccormack“We're not meant to stay in the same role for 5, 10, 15 years and feel nothing.” – Tiarna Mccormack“Clarity in your career isn't found in a spreadsheet—it's found in your story.” – Susanna GrayAbout Tiarna MccormackTiarna Mccormack is a recruitment professional with over 10 years of experience, specializing in connecting senior talent with recruitment agencies. She has held key roles, including Director, Associate Partner, and Regional Director, across sectors such as HR, Technology, Life Sciences, and Accountancy & Finance. Tiarna focuses on executive search, interim solutions, and talent acquisition while helping senior professionals achieve their career goals.Her approach centers on building strong relationships, emphasizing the importance of communication and trust in recruitment. Tiarna is also committed to coaching and mentoring, supporting individuals in unlocking their potential and advancing their careers.Outside of work, Tiarna enjoys traveling, yoga, and spending time with friends over a glass of wine. She believes in fostering meaningful connections and creating opportunities for others. For senior-level recruitment support or career advice, Tiarna is an experienced and trusted partner to collaborate with.Connect with Tiarna MccormackLinkedInFollow The Counter Offer:LinkedIn HostLinkedIn PodcastInstagramTiktok
Rackspace Technology leverages decades of experience and a cloud-first approach to help healthcare organizations optimize costs, drive transformation, and enhance security. In this episode, PV SubbaRao, Senior Vice President of Global Healthcare and Life Sciences at Rackspace Technology, shares how his organization partners with key healthcare sectors to drive innovation. He discusses Rackspace's evolution from early internet hosting to leading cloud solutions that optimize costs and enhance efficiency. PV highlights how the company supports EHR implementations, data center transformations, and security improvements, helping health systems achieve 18-25% savings. He also explores the future of healthcare technology, emphasizing AI, quantum computing, and extended reality as key drivers of personalized medicine and data-driven value. Join us and learn how Rackspace's specialized healthcare team can help your organization transform and scale for the future! Resources: Connect with and follow PV SubbaRao on LinkedIn. Learn more about Rackspace Technology on their LinkedIn and website.
三腳貓很榮幸邀請到擁有5000+粉絲的臉書粉專「實驗鼠的七分鐘廢文」的實驗鼠來跟大家分享自己從博士班開始在粉專分享生活和實驗室裡的大小事（鬼故事）的契機，想更認識實驗鼠「阿鼠姊姊」嗎？想知道粉專名稱是怎麼來的嗎？想聽更多粉專裡面沒有講到的鬼故事嗎？那就絕對不要錯過這一集！ 工作人員 內容製作：實驗鼠的七分鐘廢文、若晴、Angel 剪輯：若晴 後製：若晴 文案：若晴 封面：雯薇 上架：若晴 宣傳：Angel、雯薇 -- Hosting provided by SoundOn
Show Notes: Steven Chao, a US-born second-generation college student, shares his experiences growing up in South Carolina and feeling overwhelmed upon arriving at Harvard in 1988. He found solace in joining the Collegium Musicum, a classical musical singing group at Harvard, which helped him find his footing and connect with people from his class. From Biochem to Game Design to Consulting Steven majored in biochemistry, which expanded his social circle and helped him find happiness. Steven's parents were both PhDs and pushed him into the MD PhD program. However, he faced challenges in medical school and research, leading to questions about his path and the decision to pursue a career in computer gaming. Steven talks about his experience working in the sound and asset acquisition field at Activision in LA. He initially had a great time there but ultimately decided that it wasn't the long-term solution for him. He returned to his PhD program and he pinned his hopes on becoming a doctor. During the last half of the MD program, Steven realized that he didn't want to be a researcher or go into medicine. He found an opportunity to explore other careers beyond medicine or research through a sub-intern at McKinsey. The McKinsey Years Steven joined McKinsey full-time in 2001 and worked in the Boston office. The bulk of his work was in the payer and provider space, mainly health insurance and hospital systems. He spent about four and a half years at McKinsey, starting from scratch with no business background, which proved difficult. Steven's PhD focused on biology, not analytical skills, but rather gene genetic rearrangement and plasmids, and he felt lost at the beginning of McKinsey. At the same time, he also participated in the mini MBA program in Austria. Despite meeting great friends at McKinsey, his work was hit or miss. Steven talks about a few of the McKinsey projects he worked on and how a pharma project with Jeff Elton piqued his interest in returning to biopharma. He later worked with Kim Packard, who was his first and best mentor at McKinsey. Steven was late to promotion and advancement, and in 2004, when his wife became pregnant, he gave up his job and started considering what he would do next. Boutique Consulting, Life Sciences, and Biotech Companies In 2004, Steven joined a small consulting group at an investment bank called Leering Swan, which focused on life sciences and biotech companies. This was a better fit for Steven, who had always wanted to leverage his love for science. He joined the firm and was assigned to a project in Parkinson's disease. The experience was mind-blowing, as he interviewed world experts in this space. He was hooked within a week and found the career to be a good fit for him. The combination of his love for science and medicine, without needing to do research or have a career in clinical practice, was perfect, as he loved learning about different aspects of medicine, and the variety and diversity of the day-to-day work. Founding ClearView Steven left Leering Swan with two other people in 2008 to co-found ClearView. ClearView was born of the same concept as Leering Swan, but focused on life sciences, biotech, pharma, private equity clients, diagnostics companies, and strategic consulting. Steven's primary hat was recruiting, and he continued to love every second of doing so. ClearView Healthcare Partners is now a well-known, private consulting firm with several 100 employees. The company has a growing presence in London, India, San Francisco, New York, and Boston. Family Life and a Love of Musicals On the personal side, Steven has a family of four children, three girls and a boy. They also have two in college and two still in high school. The oldest is a sophomore at Harvard. Music has always been a significant part of their family. They have a love for Broadway musical theater, and they have spent a lot of time attending performances. Their youngest son is doing a local production of Hadestown in Wellesley, and their oldest is performing at the Agassi theater in a production of 9-5, the film with Dolly Parton, which has themes of female empowerment. Timestamps: 04:50: Transition to Medical School and Early Career Challenges 13:14: Joining McKinsey and Early Consulting Experience 23:20: Discovering a Passion for Biopharma Consulting 30:04: Founding ClearView Healthcare Partners 37:27: Personal Life and Family Featured Non-profit: Hi. This is Steve Chao, class of 1992. The featured nonprofit of this episode of The 92 report is the Merriemack Repertory Theater. My wife and I love live theater. The MRT is a fantastic organization that puts on plays and musicals every year, serving a wide catchment area in and around Lowell, Massachusetts. I was actually introduced to the MRT via a fellow class of 92 Carrie Suzawa, married named Michael. And you can learn more about the work of the MRT through the website, mrt.org. And for now, here is Will Bachman with this week's episode. To learn more about their work, visit: https:mrt.org.
The health tech fundraising environment shows promise. More deals are occurring alongside modest growth in total funding, suggesting a shift toward realistic valuations. In this episode, Julie Ebert, managing director of Healthcare and Life Sciences for Silicon Valley Bank, discusses the key findings from their annual Future of Health Tech report, highlighting the growth of AI adoption in healthcare as well as the increasing focus on specialty value-based care models. She noted a third of health tech companies that have raised money have an AI component, and half of the investment is in the administrative use of AI. Julie also explains that value-based care is moving from primary care to specialties due to these areas being complex and costly. Finally, she emphasizes that Silicon Valley Bank is playing a bold role in providing transparency to companies by offering working capital solutions and releasing reports that allow companies to have the knowledge to move forward. Tune in and learn about the current landscape of health tech investment and the future of value-based care! Resources: Connect with and follow Julie Ebert on LinkedIn. Follow Silicon Valley Bank on LinkedIn and visit their website. Read this year's SVB's Future of Healthtech report here.
In this episode of Manufacturing Hub, we welcome Amy Williams, Systems Architect at Skellig, for a deep dive into the world of life sciences manufacturing, a rarely explored but incredibly complex part of the industrial landscape.From her roots in biomolecular chemical engineering to her hands-on role in Operation Warp Speed, Amy walks us through what it's really like to build and validate manufacturing systems for pharmaceutical and biotechnology applications under FDA regulation.
Neha Sharma is a Product Manager at Grantek, she has 10+ years of experience in defining technology solutions to solve business/IT problems for manufacturers. Over the years, Neha has worked across various positions such as Software Developer, Module Lead, Techno-Functional Consultant and Manufacturing Engineer. Neha has worked for world class clients across the globe. Neha has experience in the automotive industry, packaging industry, agricultural industry, building materials, food & beverage and pharmaceuticals. The Industry 4.0 Podcast with Grantek delivers a look into the world of manufacturing, with a focus on stories and trends that lead to better solutions. Our guests will share tips and outcomes that will help improve your productivity. You will hear from leading providers of Industrial Control System hardware and software, Grantek experts and leaders at best-in-class industry associations that serve Life Sciences and Food & Beverage manufactures.
Inside INdiana Business Radio for the morning of May 1, 2025. Purdue launches a new institute in honor of a Hoosier life sciences icon. Plus, Ivy Tech Community College names its next president. Get the latest business news from throughout the state at InsideINdianaBusiness.com.
Why Startups Fail (Hint: It's Not the Innovation)In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences companies struggle to survive—and it has nothing to do with bad science.Learn the hidden pitfalls of scaling too fast, confusing innovation with execution, and chasing too many priorities at once. Carlo offers practical strategies for building focus, setting boundaries, and creating a people-first culture that actually scales. You'll also learn why execution beats experimentation when commercial success is the goal—and how to stay aligned with investors without over-promising.This conversation is packed with actionable advice for startup leaders, biotech founders, and anyone facing the complexities of early-stage growth.
"That's three hundred thousand more cases in just the past year," after a new study has come out about the neurodegenerative disease, Jim Ryan discusses the rising number of Americans facing Alzheimer's disease and age-related dementia.
On this week's episode, host Sophia McLeod is joined by Danilo Branco (Associate Director, Risk Based Quality Management Lead, BeOne Medicines) and Amanda Coogan (Associate Director, Customer Experience, Remarque Systems) to discuss the value of centralized monitoring implementation by sharing case studies from today's clinical trials. They dive deeper into how centralized monitoring can help detect adverse events more quickly and identify underreporting, the benefits of holistically monitoring trial data using centralized monitoring, and how a targeted SDV/SDR sampling strategy can help organizations to conserve resources while maintaining quality and safety.
Dublin City University's DCU Alpha and Portal Innovations from the USA.,have announced a strategic partnership to establish a new venture-building platform in Dublin, designed to support and scale indigenous Irish companies in the biotech, pharma, medtech, and deeptech sectors. This initiative comes at a crucial time for the life sciences industry in Ireland, as companies navigate an evolving global landscape marked by trade and tariff challenges. The collaboration will see the development over time of a dedicated 20,000 sq ft life sciences and deeptech innovation facility within DCU Alpha, providing startups with the space and equipment needed to thrive. The new facility will combine fully equipped wet and dry labs, incubation space, accelerator programmes, and access to a dedicated seed fund. This initiative aims to bridge the gap between university-based research and commercially viable ventures, ensuring that cutting-edge discoveries make a tangible impact on both the economy and societal health. A Catalyst for Innovation Portal Innovations, a leading venture-building firm, specialises in supporting life sciences and deeptech entrepreneurs by providing them with seed capital, world-class infrastructure, and strategic mentorship. Through this partnership, Dublin City University's Life Sciences Institute will extend its expertise and infrastructure to startups within the Portal Innovations ecosystem, granting them access to DCU's vast research networks and Core Technologies facilities at the university's Glasnevin campus. A Thriving Innovation Cluster The new Portal Innovations facility will be co-located within an already established deeptech ecosystem of pioneering companies already based at DCU Alpha, including Fire1, Deciphex, Dolmen Design, BlueBridge Technologies, Coroflo, Marama Labs, SCRI-IS, Pilot Photonics, HT Materials Science, WellAir, Taoglas, Keltech IoE, Eiratech Robotics, Ubotica, Enbio, Exergyn, and Endotronix, among others. Ronan Cunningham, Director, DCU Invent, said: "At DCU Alpha, we are committed to fostering an environment where deeptech and life sciences startups can thrive. This collaboration with Portal Innovations represents a major step forward in supporting indigenous innovation and ensuring that Ireland remains a competitive hub for scientific and technological advancements." Nancy Tyrrell, Director of Academic Partnerships at Portal Innovations, said: "Ireland has a rich history of scientific excellence, and this partnership with DCU Alpha represents a unique opportunity to accelerate the commercialisation of groundbreaking research. By bringing our proven venture-building model to Dublin, we aim to provide life sciences and deeptech entrepreneurs with the critical resources, funding, and mentorship they need to succeed on a global scale."
Quinn Dixie of Oklahoma talks with Viktor Devonne about military service, parenting, adoption, joining burlesque in one's 30s, traveling, plus the impending Burlesque Hall of Fame Weekender where she is to debut in Movers, Shakers, and Innovators. All this and and how to bump it with a trumpet accordingly, so grab yer brass. This chat was recorded on April 6, 2025. Give love to the folks… Quinn on IG: https://www.instagram.com/quinndixietheokie/ More Viktor: http://www.instagram.com/viktordevonne More WEBurlesque: http://www.instagram.com/weburlesque FOOTCLOTHES! Get 10% off your order with the code VIKTORDEVONNE at FOOTCLOTHES.COM
In this episode, Duane Mancini interviews Kelly Collier at LifeX on the dynamic life science startup ecosystem thriving in Pittsburgh. We explore the unique synergy between major academic institutions like the University of Pittsburgh and Carnegie Mellon University, and healthcare giants such as UPMC and Allegheny Health Network. Discover Kelly's entrepreneurial journey and learn how LifeX provides crucial support and programming for emerging life science companies. We also discuss the common pitfalls startups face and the specific advantages Pittsburgh offers to innovators. Tune in to understand the key ingredients fueling Pittsburgh's rise as a life science hub.Kelly Collier LinkedInLifeX WebsiteDuane Mancini LinkedInProject Medech WebsiteProject Medtech LinkedIn
IrishJobs has published the results of its Jobs Index for Q1 2025, revealing a cautious approach to hiring among firms in the Science and IT sectors ahead of the US Presidential Administration's 'Liberation Day' tariffs announcement. The total number of quarterly job vacancies increased by 5% reflecting the continued strength of the Irish economy and labour market. With close to record low levels of unemployment and moderate domestic growth, the Irish economy is in a strong position to navigate the economic volatility ahead. This economic uncertainty is set to become the new normal over the coming months due to the potential introduction of trade barriers and the emergence of a more protectionist trading environment. The uncertainty created by this shifting trading environment is already starting to impact hiring sentiment in some internationally traded sectors. There has been no change in quarterly job vacancies in either the Science or IT sector according to the Q1 Jobs Index, indicating these sectors have adopted a "wait and see" approach to hiring. The Science sector is composed of a wide range of Pharmaceutical and Life Sciences multinationals which are exposed to potential sector specific trade tariffs. This cautious hiring sentiment is also evident in the IT sector, which could be impacted by retaliatory measures levied by the EU on digital service providers. Consumer-driven sectors associated with the domestic economy, which are less directly impacted by the global trading environment experienced quarterly vacancy growth. Retail (6%), Sport and Fitness (9%), and Sales (28%) all posted strong quarterly vacancy growth. Sectoral trends The Catering sector (11%), which includes jobs in hospitality, accounted for the largest number of vacancies over the past three months. Health (7%), Sales (7%), Management (7%), and Customer Services (6%) completed the top five sectors that made up the largest number of vacancies. Consolidating a trend that emerged in Q3 2024, the Construction sector (5%) contributed marginally more job vacancies than the IT Sector (4.9%). Another property-related sector, Engineering, generated a similar proportion of job vacancies (4.6%) as the IT sector. This continues a broader trend of an uptick in construction and property related job vacancies over the course of 2024. Regional activity Findings from the Index show that several counties with large cities experienced moderate to strong increases in job vacancies, including Galway (22%), Waterford (13%), and Dublin (3%). In county Galway, Staff Nurses, Production Operators & Engineers, and Customer & Sales Assistants were some of the most in-demand roles over the quarter. Engineers, Maintenance Technicians, and Staff Nurses were among the most in-demand role in Waterford in the first three months of 2025. Hybrid and remote working trends Findings from the Index show that the proportion of hybrid working vacancies as a share of total vacancies has increased to 11% over the past three months. Over the past three quarters, the number of hybrid working vacancies as a share of total vacancies has remained stable or slightly increased. These findings suggest that hybrid working will continue to be a substantial feature of the Irish labour market over the coming months. In contrast, the share of fully remote vacancies as a proportion of overall vacancies remains relatively low at 2.4%. While there was a slight increase (0.1%) in the share of fully remote job vacancies over the past three months, their availability remains down 80.6% from the peak recorded in 2021. These trends indicate that fully remote work vacancies will likely remain stable at a relatively low level into the future. Commenting on the release of the index, Julius Probst, European Labour Market Economist at The Stepstone Group and IrishJobs, said: "The Irish labour market continues to perform well, with an exceptionally low unemployment rate of 4% paired with employment gains of about 70,0...
Host Justin Barnes recorded live at HIMSS25 in Las Vegas. Stay tuned for the next few weeks to hear all his guests.This week his guests are Tony Nunes, Senior Manager, Healthcare & Life Sciences at AMD, and Leigh Burchell, Vice President, Policy & Public Affairs at Altera Digital Health. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
In this episode of The Digital Executive, host Brian Thomas welcomes Ed Marx, a seasoned healthcare leader whose journey began humbly as a clinical janitor at 16. Ed shares how his diverse experience—from combat medic to CIO of top institutions like Cleveland Clinic and NYC Health + Hospitals—shaped his leadership style rooted in humility and service. He discusses the importance of relationships, compelling vision, and speaking the customer's language when driving digital transformation in complex healthcare environments.Currently focused on his advisory practice and board work, Ed Marx also reflects on his time at Tech Mahindra Health and Life Sciences and other leading organizations. He offers compelling insights into the next wave of healthcare innovation—from voice-driven care to hyper-personalization and advanced virtual care. Tune in for a thought-provoking conversation packed with practical wisdom and forward-looking ideas for any digital health leader.
When Your Life Sciences Are on the Line: False Claims Act by Morrison & Foerster LLP (MoFo)
In episode four of NAWL's Bridging Divides series, NAWL's Executive Director, Karen Richardson, engages in a compelling conversation with Anne Li of Crowell & Moring LLP and Ella Spottswood of Planned Parenthood Federation of America. They discuss their recent victory in a significant reproductive rights case in Missouri. Listen as our guests share their firsthand experiences and insights from working on the case, and explore the potential nationwide impact on reproductive rights. Tune in to learn more about the case and find out how you can support the organizations making a difference. Get involved with Planned Parenthood.If you are interested in partnering with Planned Parenthood as pro bono counsel, please reach out to Cecilia DosSantos, cecilia.dossantos@ppfa.org. Eleanor (Ella) Spottswood is a senior staff attorney in the litigation department at Planned Parenthood Federation of America, where she advocates to protect and expand reproductive freedoms nationwide. She recently won a preliminary injunction that allowed abortion access to resume in Missouri for the first time since Dobbs. Prior to working for Planned Parenthood, Ms. Spottswood served as the Solicitor General for Vermont, focusing on appeals and constitutional litigation. She also served for six years as the Chair of the Vermont Judicial Nominating Board.Ms. Spottswood graduated with high honors from Harvard University and earned her law degree from New York University School of Law, where she served on the board of the Law Review. After law school, she clerked on the Vermont Supreme Court and for Judge Berle Schiller of the U.S. District Court for the Eastern District of Pennsylvania. Anne Li is co-chair of the firm's Life Sciences and Patents groups. She is a first-chair trial lawyer in intellectual property who focuses on biotech, pharma, life sciences, and medical device industries. She has successfully represented clients using outside-the-box strategies, both in and out of the courtroom. Her goal is always to reach a good business resolution, but when that is not possible, she zealously uses litigation as a tool to get the best outcome for her clients. She represents clients whose groundbreaking products and services raise complex legal questions at the nexus of collaborators and competitors, including those times when one shifts to the other. She has successfully represented companies in bet-the-company litigations, often scoring key wins long before trial, resulting in favorable settlements. Companies rely on Anne to help them navigate the intersection of intellectual property and business because she provides in-house counsel with patent, unfair competition, and trade secret advice that is practical and actionable. She takes time to learn a client's business—from biotech startups to multibillion-dollar pharmaceutical companies and everything in between—so she can help them develop bespoke strategies that work for their unique situations. Clients also appreciate Anne's ability to match legal strategies with their risk tolerance and business objectives. Her approach is informed by her commitment to developing long-standing relationships with in-house counsel and her knowledge of the industry and related technologies. Furthering Anne's commitment to creating a strong and wide-reaching network across industries and the bar, Anne serves on the Executive Committee of the William C. Conner Inn of Court and is active in the NY Intellectual Property Law Association. She is also a member of Crowell's Pro Bono Committee.
AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on how AI is transforming the hiring process.
Disclaimer: This episode was recorded on April 11th, 2025, and reflects the information available at the time of recording. As we know, America is in motion here, and so subsequent updates may not be reflected in this discussion as things continue to evolve and change. Tune in as PwC specialists from across the health industry share their insights on how recent policy shifts under the Trump administration could shape healthcare in the years to come. In this episode, Glenn Hunzinger, Jenny Colapietro, and guests Kelly Griffin, Phil Sclafani, and Ruchita Kewalramani break down the potential implications of proposed government healthcare cuts, tariff policy and agency workforce reductions, along with the growing role of AI in the industry. They also discuss how pharma, medtech, payers and providers can stay ahead amidst the uncertainty. Discussion highlights:Proposed funding cuts to major government healthcare programs like Medicare, Medicaid, and NIH could significantly disrupt access, affordability, and service delivery across the healthcare landscape.Workforce reductions at federal agencies like the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Health and Human Services (HHS) may slow drug approvals, diminish oversight, and impact public health standards.New and evolving tariff policies are creating cost pressures across pharmaceutical and medtech supply chains, with potential downstream impacts on pricing, R&D, and patient access.The rapid adoption of AI in healthcare is creating new opportunities across diagnostics, R&D, and operations, while also raising concerns around governance and data privacy.To stay ahead, industry leaders must assess risks, strengthen agility, and uncover opportunities to innovate in today's dynamic environment.Speakers:Kelly Griffin, Director, Health Policy Intelligence Institute, PwCRuchita Kewalramani, Partner, Health Services PwCPhil Sclafani, Partner, Pharma & Life Sciences, PwCGlenn Hunzinger, Partner, Health Industries Leader, PwCJenny Colapietro, Principal, Consulting Commercial Leader, PwCLinked materials:Health Policy and Intelligence InstituteFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Starting a recruitment business at 25 with just three years of experience takes serious courage. Haseena Mooncey did exactly that – and she's built something special.On this week's episode of The RAG Podcast, I'm joined by Haseena Mooncey, co-founder of CHR Life Sciences, a modern boutique recruitment firm focused on niche roles across the UK, Ireland, and Europe.Haseena launched the business with a former boss as her co-founder, stepping into entrepreneurship with limited experience but a clear mindset and strong values. Her story is rare, especially as a young woman in recruitment. And it's incredibly inspiring.In this episode, we discuss:What pushed her to take the leap from employee to business ownerThe early challenges of launching with limited experienceThe mindset needed to grow a global contract recruitment businessBalancing a modern outlook with traditional values in how she builds her teamIf you're in your 20s and thinking about starting your own business - or you're just looking for a story that proves age and experience don't define success, this episode is one to tune into.Watch the full conversation live on my LinkedIn this Wednesday at 12 pm or search The RAG wherever you get your podcasts!Chapters00:00 Introduction to Haseena Mooncey and CHR Life Sciences03:00 The journey of starting a business at 2506:03 Navigating early challenges and building a network09:05 The decision to transition from employee to entrepreneur12:05 Establishing CHR Life Sciences and initial struggles14:56 First deals and market expansion18:11 Building a business from the ground up20:54 Reflections on growth and future aspirations22:00 Building relationships in recruitment24:32 Navigating market changes and opportunities26:06 The challenges of remote work and team dynamics28:06 The importance of hiring and team growth30:20 Learning from experience: hiring strategies32:32 The impact of market fluctuations on business36:52 Managing stress and maintaining team morale44:54 Building a values-driven recruitment company48:13 The role of AI in recruitment50:22 Pharmaceutical industry insights52:31 Navigating the future of work55:23 Life goals and work-life balance01:00:13 The importance of relationships in recruitmentes to try and retain as much as possible? And how much is still getting lost along the way? Traditional CRM systems weren't built for the type of recruitment business you're running right now. They were built to rely on the structured, tagged, categorised, and formal data you could feed it. Manual processes that needed you to input specific information, based on specific questions and answers. But what about all the other conversations you're having every single day? Atlas isn't an ATS or a CRM. It's an Intelligent Business Platform that helps you perform 10X better than you could on your own. How? By removing all your low value tasks, acting as your perfect memory, and providing highly relevant recommendations to impact your performance. Learn more about the power of Atlas – and take advantage of the exclusive offer for The RAG listeners – by visiting https://recruitwithatlas.com/therag/ __________________________________________Episode Sponsor: HoxoReady to find 25+ warm leads within seven days on LinkedIn?As a recruiter, most of the working day is spent...
The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They ShouldIn this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated pricing models shape what patients actually pay.You'll learn how Pharmacy Benefit Managers (PBMs) really operate, why list prices are misleading, and how pricing negotiations impact patient access. Michael also unpacks the mechanics behind patient assistance programs, the role of compounding and independent pharmacies, and how emerging technology can bring transparency and efficiency to a broken system.Whether you're in life sciences, healthcare tech, or just want to understand why your prescription costs what it does—this is a must-listen conversation.
Tom welcomes back Peter Goodburn from WaveTrack International to discuss his analysis of the financial markets. Goodburn's focus is on Elliott Wave analysis and he believes that the current market environment can be understood as a binary relation to tariffs. If tariffs continue, stock markets will decline, and gold prices will rise. Conversely, if negotiations cool off, the stock market may recover, but gold prices may experience profit-taking sell-offs. Goodburn also shared his perspective on interest rates, suggesting that Treasury yields are heading lower due to the perception of increasing inflation risks. He believes this decrease in yields indicates that a US downturn is likely, although he did not specify a timeframe for when this may occur. The interview also touched upon copper prices, with Goodburn noting that China's position on strategic metals could impact their availability and pricing going forward. As the conversation concludes, Goodburn emphasized the importance of following price levels and wave patterns instead of being overly reliant on news flow to make trading decisions. Time Stamp References:0:00 - Introduction1:00 - Analysis of the Markets3:27 - S&P Charts & Sentiment10:37 - Nasdaq Outlook13:04 - Blow-Off Technicals17:42 - Global Capital Rotation24:54 - Global Market Surveys25:37 - Dr. Copper & Tariffs31:38 - China & Rare Earths34:26 - Gold's Strength & Inflows38:12 - Gold Pullback Coming?44:47 - US Dollar Thoughts48:30 - Jerome Powell & Rates51:13 - Weak Canadian Peso54:55 - Treasuries & Yield Spikes59:22 - Tariffs & Inflation1:04:50 - Crude Oil Prices1:09:06 - Wrap Up Guest Links:Twitter: https://twitter.com/ElliottWave_WTIWebsite: https://wavetrack.com Peter Goodburn is the founding partner of WaveTrack International. His trading experience spans back to the late 1970s working then in the commodities business for exchange members and their clients. In those earlier years of his career, he created the first OTC (over-the-counter) copper option product based upon the Comex (New York) contract around the mid-eighties, and in the same period, devised Opval, an option-evaluation software program that is currently used in many of the major market-making institutions of today. His fascination with price activity and how that related to the news flow within the markets captured his imagination early on. Peter's first annual diary of 1978 records his notes and remarks on how the interaction and relationship of fundamental news and price movement often contradicted themselves. Some years later, this was to ignite his interest in causal theory and naturally, the Elliott Wave Principle. He was first introduced to the Elliott Wave Principle in the mid-eighties listening to daily updates of financial commentary by Bob Beckman on LBC radio (London Broadcasting Company). This led him to the work of Frost/Prechter and their first re-publication of R.N.Elliott's (1871-1948) original treatise of 1938 (The Wave Principle) and 1946 (Nature's Law – The Secret of the Universe), entitled "the Elliott Wave Principle" (1978). Peter's a self-proclaimed purist of the Wave Principle but has developed a unique approach of geometric Ratio & Proportion that is instrumental in maintaining a dispassionate and objective view of the market. He has applied this analysis to every major asset class over the years, stocks, bonds, currencies & commodities, and promotes the importance of interdependency of the combined group. Peter has been a member of the U.K.'s Society of Technical Analysts (STA) for over twenty-five years and is a Certified Financial Technician recognized by the International Federation of Technical Analysts (IFTA). He has taught the Elliott Wave Principle to students at the London School of Economics as part of the STA's diploma program and is a member of the Foundation for the Study of Cycles and the Society for Chaos Theory in Psychology and Life Sciences.
Accommodation requests are evolving, and life sciences employers are witnessing a surge in diverse and creative requests. Chapters 00:00 The Rise of Accommodation Requests in Life Sciences 05:44 Navigating the Interactive Process 12:10 Challenges in Fast-Paced Startups 16:57 Establishing Effective Accommodation Processes
Recorded at SCbio's 2025 annual conference, Heather and Matthew welcome Vinnie Durand of Savills, one of the world's leading property advisors. They discuss the exponential growth of the life sciences real estate market, driven by rising demand for lab and manufacturing space. Vinnie shares key considerations for life sciences companies when selecting real estate, along with insights into South Carolina's current infrastructure and its real estate opportunities for the industry. Tune in now!
Darshan's LinkedIn: https://www.linkedin.com/in/darshankulkarni/Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera
How does crowdfunding fit into a startup's fundraising strategy? In this intriguing episode of The Angel Next Door Podcast, host Marcia Dawood converses with guest Woodie Neiss about how crowdfunding has emerged as a transformative option for entrepreneurs seeking capital. The conversation unveils the ways securities-based crowdfunding is reshaping how new ventures are funded, making investments more accessible to various investors.Woodie Neiss, an experienced entrepreneur and a key advocate for crowdfunding legislation, shares his journey from Wall Street to becoming a pivotal figure in changing securities laws. His efforts have helped launch a thriving crowdfunding industry that offers over $2.8 billion in raised capital to more than 8,000 startups. He is also one of the founders of Crowdfund Capital Advisors (CCA), a crowdfunding advisory, implementation, and education firm.This episode is a must-listen for anyone involved in entrepreneurship, providing insights into significant crowdfunding developments and statistics. Woodie discusses how the industry has evolved, highlighting trends in sectors like healthcare and technology, and explaining how crowdfunding complements traditional fundraising strategies. Whether you're an investor, entrepreneur, or policymaker, this episode offers valuable perspectives on the current and future state of investment crowdfunding. To get the latest from Woodie Neiss, you can follow him below!https://www.linkedin.com/in/sherwoodneiss/https://crowdfundcapitaladvisors.com/https://a.co/d/f9987We - Investomers: How Customers-Turned-Investors are Shaping the Future of Early-Stage Finance Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood
Recorded at SCbio's 2025 annual conference, Matthew and Lauren welcome Kendalle O'Connell, President & CEO of MassBio, a powerhouse life sciences organization and the driving force behind Massachusetts' thriving life sciences ecosystem. Representing one of the strongest life sciences industries in the U.S., Kendalle shares how MassBio fosters industry success through initiatives such as their accelerator program aimed at advancing innovative science and their collaborative partnership with SCbio. Tune in for a great episode featuring one of life sciences' top leaders!
Send us a textThis episode was taped live at the ViVE 2025 conference in Nashville, Tennessee. About This EpisodePatty Hayward, General Manager of Healthcare and Life Sciences at TalkDesk, shares how personalized AI communication in healthcare is becoming reality. In a groundbreaking partnership with Epic, TalkDesk is transforming healthcare contact centers from cost-driven call hubs into vital parts of the care team, integrating support directly into electronic health records and empowering agents to guide patients with empathy and precision. Hayward dives into this evolution and makes a compelling case for co-innovation, challenging outdated metrics and redefining what truly human-centered healthcare can look like. Whether you're a healthcare professional, technology enthusiast, or simply someone who's experienced the frustration of healthcare bureaucracy, this episode offers a compelling vision of how bold thinking and strategic partnerships are creating more human-centered experiences. About Patty HaywardPatty Hayward, General Manager of Healthcare and Life Sciences at Talkdesk, has over a quarter century of industry strategy experience, including at organizations such as McKesson, Medicity, and Humedica. She is an expert in HIE, population health, pharmacy, process redesign for healthcare systems, and increasing access to patient information. Additional ResourcesLinkedIn: @PattyHaywardSupport the show-------- Stay Connected www.leighburgess.com Watch the episodes on YouTube Follow Leigh on Instagram: @theleighaburgess Follow Leigh on LinkedIn: @LeighBurgess Sign up for Leigh's bold newsletter
這集三腳貓新手村一起來聊聊大家開始怎麼漸漸習慣美國生活的呢？大家都是如何把美國當作自己的第二個家呢？來聽聽天豪、若晴及雯薇的經驗吧！ 大城市 vs 小城市 民以食為天！ 極度縮水的spinach 西方超市 vs 亞洲超市 Meal prep是讓人可以開始在家裡做東西的動力之一 一不小心吃的就講了一個小時 該如何為不同的美國氣候準備衣服呢？ Outlet及連假特價是購入衣服的好時機 圖書館有很多好用的資源！ 運動的資源很多，記得要多運動維持自己的身體健康 學會醫療保險及Student health的運作及使用方式 生小孩的帳單是多少？想知道更多的請留言！ 善用信用卡點數的點數玩家們 可以先從cash back開始累積信用 其實仔細找找也有學生票或是免費的藝文活動 大家當初想要給自己的一句話：請早點開始用退休金帳戶Roth IRA!!!! 貓與小孩 冥想 結尾：生活也是能讓自己長久追求夢想的重要因子之一 工作人員 內容製作：雯薇、若晴、天豪 後製：雯薇 文案：雯薇 音樂：雯薇 封面：雯薇 上架：雯薇 宣傳：Angel、雯薇 -- Hosting provided by SoundOn
What if you could grow health-boosting compounds—not in fields, but in bioreactors—using the power of plant cells? In this episode, Karl and Erum sit down with Ilan Sobel, CEO of BioHarvest, to explore how the company is reshaping biotech, nutraceuticals, and biomanufacturing. From leveraging botanical synthesis to create highly bioavailable compounds like piceid resveratrol, to scaling sustainable DTC operations that rival software margins, Ilan reveals how BioHarvest is closing the gap between nature, science, and commerce. Hear how this Coca-Cola veteran is building a biological infrastructure poised to disrupt pharma, food, and beyond—one cell at a time.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at www.messaginglab.com/groweverything Chapters:00:00:00 - Kicking Off with Biotech That Prints Money00:00:21 - $9 Trillion Vanishes: Markets, Mayhem, and Monday Mood00:00:36 - Brooklyn Birthdays, Bio Buzz & Citizen Scientists Unite00:02:24 - Tariffs, Pharma, and the Future of Drug Supply Chains00:04:20 - Reddit Rabbit Holes and Underrated Science That Could Change Everything00:06:49 - Pharma's Dirty Secret: Why Cures Don't Always Win00:09:39 - Meet Ilan Sobel: From Coca-Cola Exec to Biotech World-Changer00:19:13 - What the Heck Is Botanical Synthesis? (And Why It's a Game-Changer)00:26:46 - Tiny Footprint, Massive Impact: Economics That Would Make Silicon Valley Jealous00:29:02 - How a Grape Cell Became the King of Blood Flow Supplements00:35:09 - Why Longevity Starts with Blood, Not Kale00:37:32 - The Secret Sauce Behind Supplements That Actually Work00:38:55 - How BioHarvest Orchestrated a Biotech Masterpiece00:40:20 - From Plant Cells to Profit: Scaling Biotech Like a Pro00:43:10 - Open Sourcing the Future: CDMO Deals with Global Impact00:48:47 - Making Sweeteners Smarter (And Actually Tasty)00:51:35 - Building the Tesla of Biomanufacturing—Globally00:57:39 - What's Next for BioHarvest? Legacy, Longevity, and Global ScaleLinks and Resources:BioHarvestVinia.comPwC's US Tariff Industry Analysis – Pharmaceutical, Life Science, and Medical DeviceReddit: Scientific Ideas that haven't gotten enough tractionCommon Side Effects (tv series)Genesis Machine (book)Topics Covered: biomanufacturing, botanical cellular synthesis, plant biology, phytonutrients, sweet proteins, distributed biomanufacturing, direct to consumer biotechHave a question or comment? Message us here:Text or Call (804) 505-5553 Instagram / Twitter / LinkedIn / Youtube / Grow EverythingEmail: groweverything@messaginglab.comMusic by: NihiloreProduction by: Amplafy Media
In this episode, Duane Mancini delves into the life science ecosystem in Kentucky with Christin Godale, Executive Director at LifeSciKY, and Nicholas Lyktey, Chief of Laboratory Operations at Gravity Diagnostics. Christin discusses the collaborative, bipartisan efforts driving innovation in the Commonwealth, including the launch of strategic initiatives and the benefits available to participating companies. Nicholas shares the remarkable growth story of Gravity Diagnostics, from a startup with 30 employees to a powerhouse of 330, highlighting the challenges and successes of rapid scaling. We also explore the partnership between Project Medtech and LifeSciKY and how it is shaping the future of the industry in Kentucky. Tune in to discover how strategic investments and collaborative partnerships are fueling a life science revolution in the heart of the Bluegrass State. Christin Godale, PhD LinkedInNicholas Lyktey LinkedInDuane Mancini LinkedInProject Medtech LinkedInProject Medtech Website Midwest Showcase Registration
Discussions around ultra-processed foods (UPFs) and their role in public health have gained significant traction in recent years. While some advocate for categorizing and regulating these foods due to their potential negative health effects, others argue that such classifications can oversimplify the issue and detract from more actionable dietary changes. In this episode, Dr. Duane Mellor, a registered dietitian and researcher, joins us to explore the complexities of the UPF debate. Rather than dismissing the concept outright, Dr. Mellor emphasizes the importance of nuanced discussion, bridging the gap between research findings and practical, evidence-based dietary guidance. Throughout this conversation, we unpack the broader implications of ultra-processed foods in the food system, consider how added fat, salt, and sugar contribute to public health challenges, and explore realistic approaches for dietary improvements. Guest Information Dr. Duane Mellor, PhD is a registered dietitian, academic researcher and science communicator. Dr. Mellor is currently working in clinical dietetics, working to support people, families and carers living with diabetes. Previously Dr. Mellor worked in medical education at Aston University, holding the position of Associate Dean for Public Engagement in the College of Health and Life Sciences. After initially working in the areas of clinical trials, Dr. Mellor's other research interests focused on improving nutrition and health by working with communities to celebrate their heritage through food and help tackle barriers resulting from societal inequalities. Timestamps [03:02] Interview start [06:39] Understanding the NOVA classification [09:53] Potential pitfalls and policy implications [14:52] Food science and technology perspectives [20:47] Challenges in food classification [26:13] Health equity and policy considerations [42:31] Communication and public perception [50:30] Final thoughts and advice [51:15] Key ideas segment (Premium-only) Related Resources Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Paper: Mellor, 2024 – The role of food science and technology in navigating the health issues of ultra-processed foods Go to sigmanutrition.com
© 2020-2025 Ivy Podcast Discovery LLC
